Skip to main content
Start of main content.

Institute for Evidence-Based Healthcare



The Institute delivers world-class research, engagement and training that serves as a national and international resource for scholars, clinicians, system leaders, patients and families in the implementation of evidence-based clinical care. The effective integration of research into practice contributes to the health and healthcare of Australians, influences health policy, improves global health outcomes, and enhances Bond University as a leading private and independent University.


Follow us on social media

Our purpose

We aim to improve healthcare by better understanding the causes of, and solutions to, gaps between research evidence and its application in practice.

To achieve this, we:
  • Undertake research that more closely aligns evidence and patient care.
  • Support and extend collaborations between clinicians and health researchers to achieve higher value care.
  • Enable patients and families to make evidence-informed health decisions that are congruent with their values and preferences.
  • Lead and facilitate the teaching and learning of evidence-based practice.
  • Develop young researchers for research programs in sustainable healthcare.

Our research

Our research addresses four big, neglected problems in healthcare. Our focus in these areas assists health systems to provide care that is patient-centred and informed by evidence, and enables patients to make decisions that are congruent with their values, preferences and circumstances.

Antibiotic resistance

currently leads to 30,000 avoidable deaths per year in Europe and the USA, threatens elective surgery, and foreshadows a resurgence of the bacterial diseases of the 19th century.

Read more about Antibiotic resistance


has led to a massive increase in the apparent prevalence of many diseases through definition change and overdetection, and rising healthcare costs.

Read more about Overdiagnosis

Neglected non-pharmaceutical treatments

are often as effective and as safe, or safer than their pharmaceutical cousins but are poorly described and “marketed”, and therefore little used.

Read more about Neglected non-pharmaceutical treatments

Waste in medical research

is estimated to cost over $100 billion per year from avoidable design flaws, non-publication and poor reporting, resulting in >85% avoidable waste.

Read more about Waste in medical research

Latest news

  • Global recognition for Bond researchers

    Professor Paul Glasziou AO has been named among the top 1 percent of researchers worldwide in the Clarivate Highly Cited Researchers 2023 list.

    A number of IEBH staff has also been named in Stanford University’s list of the top 2 percent of most-cited scientists.

    Read more
    Read more about Global recognition for Bond researchers
  • 2024 workshops

    The Institute for Evidence-Based Healthcare is offering a series of ONLINE live interactive workshops on how to do systematic reviews with a focus on how to improve the speed and efficiency of the review process.

    Read more about 2024 workshops
  • Professor Tammy Hoffmann OAM takes top honour at research awards

    The Vice Chancellor's Research Awards 2023 highlights recognition of traditional Indigenous knowledge as a step towards reconciliation.

    Read more
    Read more about Professor Tammy Hoffmann OAM takes top honour at research awards
  • 1 in 6 women are diagnosed with gestational diabetes. But this diagnosis may not benefit them or their babies

    We've changed how we diagnose gestational diabetes in pregnancy, and roughly doubled the number of women given the label. Has that helped more than it has harmed? The recent evidence should kick off a review - our short Conversation piece explains why.

    Read more
    Read more about 1 in 6 women are diagnosed with gestational diabetes. But this diagnosis may not benefit them or their babies
  • 2weekSR methodology tested

    In 2019, the team invented the 2weekSR methodology, to complete full, PRISMA-compliant systematic reviews (SRs) in approximately 2 weeks. Since then, we have continued to develop and adapt the 2weekSR methodology for completing larger, and more complex systematic reviews, including less experienced or inexperienced team members. The Journal of Clinical Epidemiology has just published the case series.

    Read article
    Read more about 2weekSR methodology tested
Previous Next

Learn more

About us